StockData
Natera, Inc. logo

Natera, Inc. (NTRA) stock

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$287.47−1.01 (-0.35%)

Close on Nov 17, 2026Market cap $41.44BP/E –Yield –

Natera price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Natera's price to sales ratio was 17.0× on Nov 11, 2026, against 15.5× a year earlier. Over the last 5 years it ranged from 4.8× to 22.0×, with a median of 10.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.0×+2.1
2025Dec 31, 202514.9×+2.1
2024Dec 31, 202412.8×+5.3
2023Dec 29, 20237.5×+2.5
2022Dec 30, 20225.0×−10.6
2021Dec 31, 202115.6×−7.8
2020Dec 31, 202023.5×+15.1
2019Dec 31, 20198.3×+4.8
2018Dec 31, 20183.5×+1.2
2017Dec 29, 20172.3×−0.4
2016Dec 30, 20162.7×−0.2
2015Dec 31, 20152.9×–

More Natera figures

See a number that looks wrong?